The board of Sun Pharmaceutical will meet on Tuesday to consider a proposal for buy-back of fully paid-up equity shares of the company, which would include maximum amount, maximum number of equity shares, mode of buy-back and other matters incidental thereto in accordance with the provisions of Sections 68, 69 and 70 of the Companies Act,2013. Shareholders will closely monitor the price of the issue and record date, ff the buyback is through the tender process.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.